Celgene

AGREEMENT GRADE
f
Fortune 500 Rank (2018)
224
OWLER CEO APPROVAL RATING
94/100
GLASSDOOR RATING
3.7/5
CEO
Mark J. Alles

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company’s major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients.

AG Sources

Paragraph 17 of the Agreement addressed controversies or disputes and provided that “[a]ny controversy or dispute arising out of or relating to this . . . [Agreement], or the interpretation thereof, shall be settled exclusively by arbitration . . . .” The Agreement afforded plaintiff twenty-one days to review its terms and conditions and provided that if it was not executed by the twenty-first day, the Agreement would automatically expire on the twenty-second day following plaintiff’s receipt of the Agreement. Finally the Agreement provided that it “shall not become effective until the eighth day following the date on which [plaintiff] signs it . . . .” -Donna Alexander Employee Agreement (2013) – Law.Justia.com

COMMENTS

POST A COMMENT